Skip to main content
Erschienen in: Intensive Care Medicine 12/2016

13.10.2016 | Correspondence

Infection management in patients with sepsis and septic shock in resource-limited settings: focus on appropriate antimicrobial

verfasst von: Ashraf Roshdy

Erschienen in: Intensive Care Medicine | Ausgabe 12/2016

Einloggen, um Zugang zu erhalten

Excerpt

Dear Editor, …
Literatur
1.
Zurück zum Zitat Thwaites CL, Lundeg G, Dondorp AM et al (2016) Recommendations for infection management in patients with sepsis and septic shock in resource-limited settings. Intensive Care Med. doi:10.1007/s00134-016-4415-3 Thwaites CL, Lundeg G, Dondorp AM et al (2016) Recommendations for infection management in patients with sepsis and septic shock in resource-limited settings. Intensive Care Med. doi:10.​1007/​s00134-016-4415-3
2.
Zurück zum Zitat Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS et al (2013) Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2012. Intensive Care Med 39(2):165–228. doi:10.1007/s00134-012-2769-8 CrossRefPubMed Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS et al (2013) Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2012. Intensive Care Med 39(2):165–228. doi:10.​1007/​s00134-012-2769-8 CrossRefPubMed
3.
Zurück zum Zitat Kalil AC, Metersky ML, Klompas M, Muscedere J, Sweeney DA, Palmer LB, Napolitano LM, O’Grady NP, Bartlett JG et al (2016) Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis. doi:10.1093/cid/ciw353 Kalil AC, Metersky ML, Klompas M, Muscedere J, Sweeney DA, Palmer LB, Napolitano LM, O’Grady NP, Bartlett JG et al (2016) Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis. doi:10.​1093/​cid/​ciw353
4.
Zurück zum Zitat Laxminarayan R, Duse A, Wattal C, Zaidi AK, Wertheim HF, Sumpradit N, Vlieghe E, Hara GL, Gould IM, Goossens H, Greko C, So AD, Bigdeli M, Tomson G, Woodhouse W, Ombaka E, Peralta AQ, Qamar FN, Mir F, Kariuki S, Bhutta ZA, Coates A, Bergstrom R, Wright GD, Brown ED, Cars O (2013) Antibiotic resistance-the need for global solutions. Lancet Infect Dis 13(12):1057–1098. doi:10.1016/S1473-3099(13)70318-9 CrossRefPubMed Laxminarayan R, Duse A, Wattal C, Zaidi AK, Wertheim HF, Sumpradit N, Vlieghe E, Hara GL, Gould IM, Goossens H, Greko C, So AD, Bigdeli M, Tomson G, Woodhouse W, Ombaka E, Peralta AQ, Qamar FN, Mir F, Kariuki S, Bhutta ZA, Coates A, Bergstrom R, Wright GD, Brown ED, Cars O (2013) Antibiotic resistance-the need for global solutions. Lancet Infect Dis 13(12):1057–1098. doi:10.​1016/​S1473-3099(13)70318-9 CrossRefPubMed
6.
Zurück zum Zitat De Smet AM, Kluytmans JA, Cooper BS, Mascini EM, Benus RF, van der Werf TS, van der Hoeven JG, Pickkers P, Bogaers-Hofman D et al (2009) Decontamination of the digestive tract and oropharynx in ICU patients. N Engl J Med 360(1):20–31. doi:10.1056/NEJMoa0800394 CrossRefPubMed De Smet AM, Kluytmans JA, Cooper BS, Mascini EM, Benus RF, van der Werf TS, van der Hoeven JG, Pickkers P, Bogaers-Hofman D et al (2009) Decontamination of the digestive tract and oropharynx in ICU patients. N Engl J Med 360(1):20–31. doi:10.​1056/​NEJMoa0800394 CrossRefPubMed
7.
Zurück zum Zitat Price R, MacLennan G, Glen J, SuDDICU Collaboration (2014) Selective digestive or oropharyngeal decontamination and topical oropharyngeal chlorhexidine for prevention of death in general intensive care: systematic review and network meta-analysis. BMJ 348:g2197. doi:10.1136/bmj.g2197 CrossRefPubMedPubMedCentral Price R, MacLennan G, Glen J, SuDDICU Collaboration (2014) Selective digestive or oropharyngeal decontamination and topical oropharyngeal chlorhexidine for prevention of death in general intensive care: systematic review and network meta-analysis. BMJ 348:g2197. doi:10.​1136/​bmj.​g2197 CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat De Bus L, Denys W, Catteeuw J, Gadeyne B, Vermeulen K, Boelens J, Claeys G, De Waele JJ, Decruyenaere J, Depuydt PO (2016) Impact of de-escalation of beta-lactam antibiotics on the emergence of antibiotic resistance in ICU patients: a retrospective observational study. Intensive Care Med 42(6):1029–1039. doi:10.1007/s00134-016-4301-z CrossRefPubMed De Bus L, Denys W, Catteeuw J, Gadeyne B, Vermeulen K, Boelens J, Claeys G, De Waele JJ, Decruyenaere J, Depuydt PO (2016) Impact of de-escalation of beta-lactam antibiotics on the emergence of antibiotic resistance in ICU patients: a retrospective observational study. Intensive Care Med 42(6):1029–1039. doi:10.​1007/​s00134-016-4301-z CrossRefPubMed
10.
Zurück zum Zitat Richard Smith, Joanna Coast (2013) The true cost of antimicrobial resistance. BMJ 346:f1493CrossRef Richard Smith, Joanna Coast (2013) The true cost of antimicrobial resistance. BMJ 346:f1493CrossRef
11.
Metadaten
Titel
Infection management in patients with sepsis and septic shock in resource-limited settings: focus on appropriate antimicrobial
verfasst von
Ashraf Roshdy
Publikationsdatum
13.10.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Intensive Care Medicine / Ausgabe 12/2016
Print ISSN: 0342-4642
Elektronische ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-016-4473-6

Weitere Artikel der Ausgabe 12/2016

Intensive Care Medicine 12/2016 Zur Ausgabe

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.